Relationship Between Thyroid Dysfunction and Diabetes
Metabolic Syndrome and Thyroid Dysfunction in Type 2 Diabetes In Upper Egypt
1 other identifier
observational
120
0 countries
N/A
Brief Summary
Evaluate the expression of glycemic parameters, lipid profile, and thyroid hormones in patients with type 2 diabetes mellitus in upper egypt.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 18, 2025
CompletedFirst Posted
Study publicly available on registry
August 1, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
August 1, 2025
July 1, 2025
1 year
July 18, 2025
July 30, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Prevalence of thyroid dysfunction among type 2 diabetic patients
The outcome will measure the proportion (%) of type 2 diabetic patients diagnosed with thyroid dysfunction. This includes classification into hypothyroidism, hyperthyroidism, subclinical hypothyroidism, and subclinical hyperthyroidism based on standard laboratory cutoffs of TSH, free T3, and free T4.
Baseline
Association between thyroid dysfunction and metabolic syndrome in type 2 diabetic patients
The outcome will assess the statistical correlation (e.g., chi-square test or logistic regression) between the presence of thyroid dysfunction and the diagnosis of metabolic syndrome, according to IDF criteria. Results will be reported as odds ratios or p-values as appropriate.
Baseline
Interventions
This study does not involve any intervention. It is a cross-sectional observational study. The term "intervention" here refers to laboratory investigations and clinical assessments conducted as part of data collection only.
Eligibility Criteria
Adult patients aged 18 years and above diagnosed with type 2 diabetes mellitus attending the Diabetes and Endocrinology Outpatient Clinic at Assiut University Hospitals, Upper Egypt.
You may qualify if:
- Patients diagnosed with type 2 diabetes mellitus in upper egypt.
- Age above 18 years.
- Patients who gave informed consent to participate.
You may not qualify if:
- Patients with type 1 diabetes mellitus.
- Age below 18 years.
- Patients with known autoimmune thyroid diseases, pregnancy, or acute illness at the time of assessment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (4)
Sakamoto M. Type 2 Diabetes and Glycemic Variability: Various Parameters in Clinical Practice. J Clin Med Res. 2018 Oct;10(10):737-742. doi: 10.14740/jocmr3556w. Epub 2018 Sep 10.
PMID: 30214644BACKGROUNDFord ES, Li C, Sattar N. Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care. 2008 Sep;31(9):1898-904. doi: 10.2337/dc08-0423. Epub 2008 Jun 30.
PMID: 18591398BACKGROUNDHadgu R, Worede A, Ambachew S. Prevalence of thyroid dysfunction and associated factors among adult type 2 diabetes mellitus patients, 2000-2022: a systematic review and meta-analysis. Syst Rev. 2024 Apr 30;13(1):119. doi: 10.1186/s13643-024-02527-y.
PMID: 38689302BACKGROUNDChen H, Wu J, Lyu R. Expressions of glycemic parameters, lipid profile, and thyroid hormone in patients with type 2 diabetes mellitus and their correlation. Immun Inflamm Dis. 2024 Jul;12(7):e1282. doi: 10.1002/iid3.1282.
PMID: 38967365BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- doctor
Study Record Dates
First Submitted
July 18, 2025
First Posted
August 1, 2025
Study Start
September 1, 2025
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
August 1, 2025
Record last verified: 2025-07